PepGen (PEPG) s Poised to Disrupt Rare Disease Therapy
PepGen Inc. (NASDAQ:PEPG) is a U.S.-based clinical-stage biotechnology company at the forefront of genetic medicine, focused on developing…
Enveric Biosciences (ENVB) Just Might Be the Most Undervalued Biotech in Mental Health
Enveric Biosciences Inc. (NASDAQ:ENVB) is a cutting-edge biotechnology company redefining the future of mental health treatment by developing…
Cumberland Pharma (CPIX) is Beating Big Pharma at Its Own Game
Founded in 1999 and headquartered in Nashville, Tennessee, Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is a U.S.-based specialty pharmaceutical…
FDA-Approved Rosacea Drug Just Changed the Game for Journey Medical (DERM)
Journey Medical Corporation (NASDAQ:DERM) is a U.S.-based specialty pharmaceutical company focused on treating chronic dermatological conditions through FDA-approved…
Analysts Believe DBV Tech (DBVT) Could 10x After FDA Approval
DBV Technologies S.A. (NASDAQ:DBVT) is a late-stage clinical biopharmaceutical company based in France that is pioneering a groundbreaking…
Organovo (ONVO) Just Hit Rock Bottom but Could Soar 10x From Here
Organovo Holdings Inc. (NASDAQ:ONVO) is a pioneering biotechnology company redefining the future of medicine through the science of…
Arcturus Therapeutics (ARCT) Could Be the Dark Horse of the Biotech Boom
Founded in 2013 and headquartered in San Diego, California, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a cutting-edge biotechnology…
Scholar Rock (SRRK): The $3 Billion Biotech You’ve Never Heard Of—But Wall Street Can’t Stop Watching
Scholar Rock Holding Corporation (NASDAQ:SRRK) is a clinical-stage biotechnology company pioneering a transformative class of therapeutics that target…
BeOne Medicines (ONC) is Quietly Taking Over the Global Cancer Drug Market
BeOne Medicines (NASDAQ:ONC) is a global biopharmaceutical company pioneering a new era of cancer care by developing innovative,…
Nevro (NVRO) Could Surge Beyond its Buyout Offer in 2025
Nevro Corp. (NYSE:NVRO) is a global medical device company at the forefront of transforming chronic pain management through…
Johnson & Johnson (JNJ) can be the Next Trillion-Dollar Stock
Johnson & Johnson (NYSE:JNJ) is one of the most iconic and enduring names in the global healthcare industry,…
Boston Scientific (BSX) Just Signed a $45M Deal—Here’s What It Means for Investors
Boston Scientific Corporation (NYSE:BSX) is a globally recognized leader in the development, manufacturing, and commercialization of innovative medical…
Procept BioRobotics (PRCT) is Heating Up — Can it Redefine Robotic Surgery?
Procept BioRobotics Corporation (NASDAQ:PRCT) is a pioneering surgical robotics company that has set its sights on revolutionizing the…
This Tiny Surgical Robot Stock Could Disrupt a $30 Billion Industry: Microbot Medical (MBOT)
Microbot Medical Inc. (NASDAQ:MBOT) is a cutting-edge, pre-commercial stage medical technology company on a mission to transform the…
Pro-Dex (PDEX) Plunges 39% – Here’s Why Smart Investors Are Buying the Dip
Pro-Dex Inc. (NASDAQ:PDEX) is a U.S.-based medical technology company renowned for its engineering expertise in designing and manufacturing…
Sensus Healthcare (SRTS) can be the Next 5X Medical Device Stock
Sensus Healthcare, Inc. (NASDAQ:SRTS) is a cutting-edge medical device company dedicated to transforming the treatment of non-melanoma skin…
Integra LifeSciences (IART) is the Most Undervalued Medtech Stock You’re Not Watching
Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a pioneering global medical technology company that has built a strong reputation…
Wall Street is Sleeping on Globus Medical (GMED)—Here’s Why You Shouldn’t
Globus Medical Inc. (NYSE:GMED) is a leading medical technology company at the forefront of transforming the musculoskeletal healthcare…